Long-term Efficacy and Predictors of Response to Infliximab in Korean Patients with Crohn's Disease.
10.4166/kjg.2013.61.5.241
- Author:
Kang Moon LEE
1
Author Information
1. Department of Internal Medicine, St. Vincent Hospital, The Catholic University of Korea College of Medicine, Suwon, Korea. drmaloman@catholic.ac.kr
- Publication Type:Comment ; Editorial
- MeSH:
Antibodies, Monoclonal/*therapeutic use;
Crohn Disease/*drug therapy;
Female;
Gastrointestinal Agents/*therapeutic use;
Humans;
Male
- From:The Korean Journal of Gastroenterology
2013;61(5):241-242
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
No abstract available.
